Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EAST BRUNSWICK, N.J., Oct. 27, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, President of Savient Pharmaceuticals will be presenting at the...
-
EAST BRUNSWICK, N.J., Oct. 1, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, President of Savient Pharmaceuticals, will be presenting at the...
-
EAST BRUNSWICK, N.J., June 5, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Ginger D. Constantine, M.D. has been elected to the Company's Board of...
-
EAST BRUNSWICK, N.J., May 29, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that six abstracts (two oral presentations and four posters) about the Company's...
-
EAST BRUNSWICK, N.J., May 1, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, President of Savient Pharmaceuticals, will be presenting at the...
-
EAST BRUNSWICK, N.J., April 24, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that the company will release financial results for the first quarter 2009...